ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

September 1, 2025

Study Completion Date

November 1, 2025

Conditions
Colorectal CancerEarly Detection of Cancer
Interventions
BEHAVIORAL

Control

Electronic educational materials

BEHAVIORAL

Patient activation

Interactive text messages with links to videos (e.g. colorectal cancer screening options, cost of colorectal cancer screening, perspective from a cancer survivor, why regular appointments are important for cancer survivors) and resources (e.g. helpful websites) are sent to participants

BEHAVIORAL

Primary care provider activation

Faxed educational materials (e.g. current colorectal cancer screening recommendations, frequently asked questions, insurance letter template, cover letter with overview of patient's cancer treatment history) sent to primary care providers

Trial Locations (4)

10017

Memorial Sloan Kettering Cancer Center, New York

10027

Columbia University, New York

16802

The Pennsylvania State University, University Park

38105

St. Jude Children's Research Hospital, Memphis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

St. Jude Children's Research Hospital

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

Columbia University

OTHER

collaborator

The Hospital for Sick Children

OTHER

collaborator

Duke University

OTHER

collaborator

Penn State University

OTHER

collaborator

Hunter College of City University of New York

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT05084833 - ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study | Biotech Hunter | Biotech Hunter